Impact of medication therapy management on pharmacotherapy safety in an intensive care unit
- 15 December 2018
- journal article
- research article
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 41 (1) , 179-188
Abstract
Background Drug-related problems are mostly preventable or predictable circumstances that may impact on health outcomes. Clinical pharmacy activities such as medication therapy management can identify and solve these problems, with potential to improve medication safety and effectiveness. Objective To evaluate ability of medication therapy management service to detect drug-related problems and prevent adverse drug events. This study also aimed to assess the risk factors for drugrelated problem occurrence. Setting Medical intensive care unit of a public tertiary hospital in Brazil. Methods Patients were evaluated by a clinical pharmacist, who provided medication therapy management service. Detected drug-related problems were categorized according to the Pharmaceutical Care Network Europe methodology and analyzed in multinomial regression to identify risk factors. Main outcome measure Potential risk factors for drug-related problem occurrence. Results The proposed medication therapy management service allowed detection of 170 drug-related problems that had potential to reach patients causing harm and other 50 unavoidable adverse events. Drug-related problems identified were more often associated with antibacterial use, caused by improper combinations or inadequate drug dosage. These problems required interventions that were accepted by the multidisciplinary team, resulting in more than 85% adherence and total problem solving. Main risk factors identified were previous diagnosis of kidney injury (OR = 8.38), use of midazolam (OR = 7.96), furosemide (OR = 5.87) and vancomycin (OR = 4.82). Conclusion Medication therapy management proved to be an effective method not only for drug-related problem detection, but also for adverse drug event prevention, contributing to improve patient safety.Keywords
Funding Information
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (Finance Code 001 - AUXPE 1665/2016)
- Fundação de Amparo à Pesquisa do Estado de Goiás
This publication has 40 references indexed in Scilit:
- Impact of clinical pharmacist interventions on the cost of drug therapy in intensive care units of a tertiary care teaching hospitalJournal of Pharmacology and Pharmacotherapeutics, 2012
- Analysis of risk factors for adverse drug events in critically ill patients*Critical Care Medicine, 2012
- Overutilization of proton-pump inhibitors: what the clinician needs to knowTherapeutic Advances in Gastroenterology, 2012
- On-ward participation of a hospital pharmacist in a Dutch intensive care unit reduces prescribing errors and related patient harm: an intervention studyCritical Care, 2010
- Adverse drug reactions in medical intensive care unit of a tertiary care hospitalPharmacoepidemiology and Drug Safety, 2009
- Incidence of Adverse Drug Events and Medication Errors in Intensive Care UnitsJournal of Patient Safety, 2009
- SAPS 3—From evaluation of the patient to evaluation of the intensive care unit. Part 2: Development of a prognostic model for hospital mortality at ICU admissionIntensive Care Medicine, 2005
- SAPS 3—From evaluation of the patient to evaluation of the intensive care unit. Part 1: Objectives, methods and cohort descriptionIntensive Care Medicine, 2005
- Prescription errors in UK critical care unitsAnaesthesia, 2004
- The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failureIntensive Care Medicine, 1996